Watch ODTX. Know when insiders buy.
One email the day a filing lands. Free.
ODTX
Odyssey Therapeutics, Inc.
19.00
+0.01 +0.05%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
55
WATCH · shorts 55
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
FINANCIALS: NOT YET PULLED FROM SEC XBRL, CHECK BACK AFTER TONIGHT52W 15.56 – 28.76
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $0 | — | — | −$55.5M | −$52.8M | — | -1.74 | −$34.5M | $186K | −$34.7M | Aug 6 |
| Q1 2026 · Mar 31 | $0 | — | — | −$39.8M | −$38.3M | — | -6.77 | −$41M | $148K | −$41.2M | Aug 6 |
| Q2 2025 · Jun 30 | $959K | — | — | −$41.9M | −$41.2M | — | -29.54 | −$34.3M | $29K | −$34.3M | Aug 6 |
| Q1 2025 · Mar 31 | $1.9M | — | — | −$39.2M | −$38.4M | — | -39.37 | −$38.6M | $927K | −$39.5M | Aug 6 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|
Every number comes from Odyssey Therapeutics, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.